Health tech deals
Bristol-based EnsiliTech has raised its second oversubscribed funding round, securing £4.5m in seed funding to improve how life-saving medicines are stored and delivered worldwide. The company’s Ensilication process allows medicines to withstand temperatures up to 50°C. The funding will speed up proof-of-concept adoption for both existing and new biopharmaceuticals, expand capacity through new hires and [...]
OrganOx, a company that makes devices to keep organs alive outside the human body, has been bought by Japan’s Terumo Corporation in a “landmark” US$1.5bn (£1.1bn) deal. The Oxford University spin-out’s technology has preserved organs for transplantation and, according to its creators, has already saved 6,000 lives. The machines maintain organs by recreating body-like conditions [...]
International law firm McDermott Will & Schulte advised Five Arrows Manager SAS (as sponsor) and Axis Arbor (as debt advisor) in connection with a financing made available by Morgan Stanley and McQuarie Group for the Sponsor's acquisition of Hublo. Hublo is a company focused on transforming healthcare by improving how human resources are managed within [...]
Health Tech World explores the latest business and pharmaceutical developments in the world of health technology. AI platform to accelerate medical and epidemiological research Health technology company Briya has announced the launch of Briya AIRE, the world's first clinical-grade AI research assistant built to accelerate biomedical and clinical decision making. Designed to "think" in the [...]
Neurovalens, a Belfast-based neurotech company, has raised £6m (€6.95m) to support its commercial expansion in the US and other global markets. The funds will be used to boost sales of its current medical devices and pursue additional approvals from US regulators. Its technology delivers mild electrical stimulation to targeted parts of the brain and nervous [...]
McDermott Will & Schulte advised funds managed by Oaktree Capital Management, L.P. (“Oaktree”) in connection with a new four-year term loan facility of up to $125 million provided to OXB (LSE: OXB), a leading cell and gene therapy contract development and manufacturing organization (CDMO). The facility includes $60 million in initial funding, the majority of [...]
Venture capital firm Apollo Health Ventures is funding and co-founding early-stage companies that are transforming age-related diseases and ageing. Health Tech World speaks to co-founder Dr Alexandra Bause to find out more. Founded in 2017, Apollo Health Ventures has, to date, invested in 15 companies that are innovating in the longevity space. From DNA damage [...]
Apreo Health, a clinical-stage medical device company developing a novel treatment for severe emphysema, has announced the closing of an oversubscribed $130 million Series B financing round. The financing was co-led by new investors Bain Capital Life Sciences and Norwest, with participation from new investors F-Prime and Intuitive Ventures. Returning investors Lightstone Ventures and Santé [...]
Ergéa and Newton’s Tree have announced a strategic partnership aimed at transforming healthcare organisations through integrated, AI-enabled digital solutions. This collaboration brings together Ergéa’s deep expertise in lifecycle management of medical equipment and Newton’s Tree’s cutting-edge platform for deploying and monitoring AI applications across clinical and operational domains. Together, they will deliver a comprehensive, vendor-neutral [...]
System C today announced the acquisition of Australian health and care management tech provider MYP Technologies. This strategic move deepens System C’s presence in the region and supports ambitious plans to expand its social care and maternity product offerings across Australia and New Zealand. The acquisition marks a significant step in System C’s international growth [...]
